Literature DB >> 16399770

Neurotropic viruses and cerebral palsy: population based case-control study.

Catherine S Gibson1, Alastair H MacLennan, Paul N Goldwater, Eric A Haan, Kevin Priest, Gustaaf A Dekker.   

Abstract

OBJECTIVE: To investigate the association between cerebral palsy and direct evidence for perinatal exposure to neurotropic viruses.
DESIGN: Population based case-control study.
SETTING: Adelaide Women's and Children's Hospital Research Laboratory. PARTICIPANTS AND MAIN OUTCOME MEASURES: Newborn screening cards of 443 white case patients with cerebral palsy and 883 white controls were tested for viral nucleic acids from enteroviruses and herpes viruses by using polymerase chain reaction. Herpes group A viruses included herpes simplex viruses 1 and 2 (HSV-1 and HSV-2), Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpes virus 8 (HHV-8), and herpes group B viruses included varicella zoster virus (VZV) and human herpes viruses 6 and 7 (HHV-6 and HHV-7).
RESULTS: The prevalence of viral nucleic acids in the control population was high: 39.8% of controls tested positive, and the prevalence was highest in preterm babies. The detection of herpes group B viral nucleic acids increased the risk of developing cerebral palsy (odds ratio 1.68, 95% confidence interval 1.09 to 2.59).
CONCLUSIONS: Perinatal exposure to neurotropic viruses is associated with preterm delivery and cerebral palsy.

Entities:  

Mesh:

Year:  2006        PMID: 16399770      PMCID: PMC1326927          DOI: 10.1136/bmj.38668.616806.3A

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  27 in total

Review 1.  The role of infection in preterm labour.

Authors:  Klaus Friese
Journal:  BJOG       Date:  2003-04       Impact factor: 6.531

2.  Congenital anomalies following maternal varicella infection during early pregnancy.

Authors:  Y C Huang; T Y Lin; K S Wong; C H Chiu
Journal:  J Formos Med Assoc       Date:  1996-05       Impact factor: 3.282

3.  Detection of viral deoxyribonucleic acid in the amniotic fluid of low-risk pregnancies by polymerase chain reaction.

Authors:  L K McLean; F F Chehab; J D Goldberg
Journal:  Am J Obstet Gynecol       Date:  1995-10       Impact factor: 8.661

4.  The development of the human blood-CSF-brain barrier.

Authors:  M Adinolfi
Journal:  Dev Med Child Neurol       Date:  1985-08       Impact factor: 5.449

5.  Diagnosis of horizontal enterovirus infections in neonates by nested PCR and direct sequence analysis.

Authors:  T Takami; S Sonodat; H Houjyo; H Kawashima; Y Takei; T Miyajima; K Takekuma; A Hoshika; T Mori; T Nakayama
Journal:  J Hosp Infect       Date:  2000-08       Impact factor: 3.926

6.  Comprehensive PCR-based assay for detection and species identification of human herpesviruses.

Authors:  G Johnson; S Nelson; M Petric; R Tellier
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Reverse transcription of an RNA genome from databasing paper (FTA(R)).

Authors:  C D Rogers; L A Burgoyne
Journal:  Biotechnol Appl Biochem       Date:  2000-06       Impact factor: 2.431

8.  Maternal intrauterine herpes simplex virus infection leading to persistent fetal vasculature.

Authors:  R P Corey; J T Flynn
Journal:  Arch Ophthalmol       Date:  2000-06

9.  Intrauterine viral infection at the time of second trimester genetic amniocentesis.

Authors:  K D Wenstrom; W W Andrews; N E Bowles; J A Towbin; J C Hauth; R L Goldenberg
Journal:  Obstet Gynecol       Date:  1998-09       Impact factor: 7.661

Review 10.  Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth.

Authors:  Ronald F Lamont
Journal:  BJOG       Date:  2003-04       Impact factor: 6.531

View more
  12 in total

1.  Cerebral palsy and perinatal exposure to neurotropic viruses.

Authors:  Eva Alberman; Catherine Peckham
Journal:  BMJ       Date:  2006-01-14

Review 2.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

3.  Candidate genes and risk for CP: a population-based study.

Authors:  Yvonne W Wu; Lisa A Croen; Andrew Vanderwerf; Amy A Gelfand; Anthony R Torres
Journal:  Pediatr Res       Date:  2011-12       Impact factor: 3.756

4.  Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research.

Authors:  Gai L McMichael; Amanda R Highet; Catherine S Gibson; Paul N Goldwater; Michael E O'Callaghan; Emily R Alvino; Alastair H MacLennan
Journal:  J Biomol Tech       Date:  2011-04

Review 5.  Risks associated with viral infections during pregnancy.

Authors:  Karen Racicot; Gil Mor
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

6.  Association between Apolipoprotein E genotype and cerebral palsy is not confirmed in a Caucasian population.

Authors:  Gai L McMichael; Catherine S Gibson; Paul N Goldwater; Eric A Haan; Kevin Priest; Gustaaf A Dekker; Alastair H MacLennan
Journal:  Hum Genet       Date:  2008-09-23       Impact factor: 4.132

7.  TNF-α and MTHFR Polymorphisms Associated with Cerebral Palsy in Chinese Infants.

Authors:  Ruiying Hou; Xiuyu Ren; Juan Wang; Xujun Guan
Journal:  Mol Neurobiol       Date:  2015-12-08       Impact factor: 5.590

8.  Prevalence and pathogenesis of congenital anomalies in cerebral palsy.

Authors:  Peter O D Pharoah
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-04-11       Impact factor: 5.747

9.  TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals.

Authors:  Onur Numan; Fisun Vural; Nurettin Aka; Murat Alpay; Ayse Deniz Erturk Coskun
Journal:  North Clin Istanb       Date:  2015-12-25

10.  Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States.

Authors:  Kathleen M Muldoon; Amy Armstrong-Heimsoth; Jodi Thomas
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.